[eDisclosure Notice] KOSDAQ - 3 Days

< Major Announcements After Market Close >

◆ Alpha Holdings = Decided on a paid-in capital increase worth 10 billion KRW to raise operating funds

◆ Kolon TissueGene = Completed the U.S. Food and Drug Administration (FDA) review process for the protocol of the U.S. Phase 2 clinical trial of 'TG-C' for hip osteoarthritis. If no issues are found in the result analysis, entry into large-scale clinical trials (Phase 3) is possible

◆ iWons = Largest shareholder and CEO Moon-ki Lee signed a contract to transfer 24.58% of shares to Hansol Technics for approximately 86.6 billion KRW

◆ Farm Story = Subsidiary Farms World decided on a 30 billion KRW shareholder allocation capital increase to repay debt

◆ Lemon = Designated as an unfaithful disclosure company due to delayed disclosure regarding lawsuits and other filings

◆ Hyunjin Materials = Filed for rehabilitation proceedings at Seoul Rehabilitation Court on the 3rd

This content was produced with the assistance of AI translation services.